Briquilimab

BRIQUILIMAB®

Overview

Briquilimab is an anti-CD117 monoclonal antibody that is being studied for use in several different indications.

SparkCures ID 700
Brand Name Briquilimab®
Generic Name Briquilimab
Additional Names JSP191
Treatment Classifications
Treatment Targets
  • CD117

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.